Marek Łoś
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Molecular Biology top 0.5%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
Papers in
-
- Cell death mechanisms and regulation 38
- RNA Interference and Gene Delivery 13
- Epidemiology 30
- Autophagy in Disease and Therapy 24
- Co-authors
- Klaus Schulze‐Osthoff (31 shared papers)Sebastian Wesselborg (12 shared papers)Saeid Ghavami (68 shared papers)Davide Ferrari (4 shared papers)Mohammad Hashemi (15 shared papers)Thomas Klonisch (18 shared papers)Patrick A. Baeuerle (4 shared papers)Marcus E. Peter (2 shared papers)
In The Last Decade
Marek Łoś
166 papers receiving 13.1k citations
Marek Łoś's Hit Papers
Peers
Comparison fields: 5 of 163
- Cancer Research 1.5k
- Molecular Biology 7.1k
- Physiology 443
- Immunology 1.9k
- Oncology 2.2k
Countries citing papers authored by Marek Łoś
This map shows the geographic impact of Marek Łoś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Łoś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Łoś more than expected).
Fields of papers citing papers by Marek Łoś
This network shows the impact of papers produced by Marek Łoś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Łoś. The network helps show where Marek Łoś may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Łoś, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autophagy and apoptosis dysfunction in neurodegenerative disorders Hit paper breakdown → | 2013 | 849 |
| 2 | Apoptosis signaling by death receptors Hit paper breakdown → | 1998 | 814 |
| 3 | Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis Hit paper breakdown → | 1995 | 567 |
| 4 | 1997 | 481 | |
| 5 | 2002 | 419 | |
| 6 | 1999 | 341 | |
| 7 | 2008 | 321 | |
| 8 | 1999 | 264 | |
| 9 | 2008 | 261 | |
| 10 | 1999 | 242 | |
| 11 | 2012 | 234 | |
| 12 | 1995 | 225 | |
| 13 | 2009 | 211 | |
| 14 | 2019 | 209 | |
| 15 | 2013 | 196 | |
| 16 | An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment Hit paper breakdown → | 2021 | 186 |
| 17 | 1998 | 181 | |
| 18 | 2018 | 177 | |
| 19 | 1997 | 173 | |
| 20 | 1995 | 172 |
About Marek Łoś
Marek Łoś is a scholar working on Molecular Biology, Epidemiology, Oncology, Immunology and Cancer Research, having authored 167 papers that have together received 13.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (38 papers), Autophagy in Disease and Therapy (24 papers), RNA Interference and Gene Delivery (13 papers), Tissue Engineering and Regenerative Medicine (9 papers), Endoplasmic Reticulum Stress and Disease (9 papers), Cancer-related Molecular Pathways (8 papers), Cancer Cells and Metastasis (7 papers) and Electrospun Nanofibers in Biomedical Applications (7 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (7.1k citations), Physiology (443 citations), Immunology (1.9k citations) and Oncology (2.2k citations). Marek Łoś has collaborated with scholars based in Canada, Poland and Iran. Frequent co-authors include Klaus Schulze‐Osthoff, Sebastian Wesselborg, Saeid Ghavami, Davide Ferrari, Mohammad Hashemi, Thomas Klonisch, Patrick A. Baeuerle, Marcus E. Peter, Sudharsana Rao Ande and Subbareddy Maddika. Their work appears in journals such as European Journal of Pharmacology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, International Journal of Molecular Sciences, Archivum Immunologiae et Therapiae Experimentalis and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.